The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy

Abroad (travel likely)RecruitingPHASE2

Conditions

Drug Resistant Epilepsy · Medically Refractory Epilepsy · Refractory Epilepsy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Mount Sinai Hospital, New York, New York, United States

    Contact: Study coordinator (Onome Eka, MBBS MPH) · onome.eka@mssm.edu · 9179825055
    Contact: Principal Investigator (Madeline Fields)
Study leads
  • Madeline Fields, MD

    Principal Investigator

    Icahn School of Medicine

  • Lara Marcuse, MD

    Principal Investigator

    Icahn School of Medicine